AIM-HI Announces Semi-Finalists in Women’s Venture Competition, Finalists Announced Sept. 24

The 8 semi-finalists are just announced in the AIM-HI Accelerator Fund’s inaugural Women’s Venture Competition! These innovative oncology startups are selected from an exceptional pool of high quality women entrepreneur applications, by a Selection Committee comprised of world-class key opinion leaders, life sciences industry experts, investors, and entrepreneurs.

The Women’s Venture Competition is one of the first venture-backed competitions focusing on women in the life sciences, specifically, female-created and female-managed oncology start-ups. It’s no secret that the life sciences industry suffers from a lack of gender diversity at all levels and at all stages of developing new therapeutics and technologies. The Women’s Venture Competition aims to start changing this gender imbalance and give women the boost they need.

The 8 semi-finalists will also receive accelerator boot camp support by Springboard Enterprises, one of the world’s most renowned entrepreneur accelerator programs for women. These semi-finalists will be advanced to the final Pitch Competition in front of the Judging Committee on September 24, 2020.

The winner will receive an equity investment of $300,000 by AIM-HI, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials, and eventually, to therapeutics that could save patients’ lives. For example, $300,000 could fund a critically needed toxicity study, which is one of the bottlenecks due to lacking of early investments for oncology startup companies.

Please join us in congratulating these 8 women and their companies, and save the date for the Award Ceremony on Thursday, September 24, during which the finalists will be announced.

Learn more about the AIM-HI Women’s Venture Competition